To the best of our knowledge, this is the largest analysis of RCTs examining obesity as a prognostic factor in operable BC patients treated with anthracyclines and taxanes, and adjusting for hormone receptor and HER2 status. The gene discussed is NR4A1; the disease is obesity disorder.